Dose effects of corticosteroids on the development of osteonecrosis in rabbits

Journal of Rheumatology

Volumn 35, Issue 12, 2008, Pages 2395-2399

  Motomura, Goro ^a   Yamamoto, Takuaki ^a,b   Irisa, Takahiko ^a   Miyanishi, Keita ^a   Nishida, Kenjiro ^a   Iwamoto, Yukihide ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Animal model; Corticosteroid; Dose; Osteonecrosis

Indexed keywords

CHOLESTEROL; CORTICOSTEROID; METHYLPREDNISOLONE ACETATE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD EXAMINATION; BLOOD SAMPLING; BONE NECROSIS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; FEMUR; HISTOPATHOLOGY; HUMERUS; HYPERLIPIDEMIA; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RABBIT; THROMBOCYTE; THROMBOCYTOPENIA; TRIACYLGLYCEROL BLOOD LEVEL;

ADRENAL CORTEX HORMONES; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHYLPREDNISOLONE; OSTEONECROSIS; RABBITS;

EID: 57349153107     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080324     Document Type: Article

References (18)

1. Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am 2006;88:1117-32.
2. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 1995;77:459-74.
3. Nagasawa K, Tada Y, Koarada S, et al. Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. Lupus 2005;14:385-90.
4. Griffith JF, Antonio GE, Kumta SM, et al. Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids. Radiology 2005;235:168-75.
5. Mok CC, Lau CS, Wong RW. Risk factors for avascular bone necrosis in systemic lupus erythematosus. Br J Rheumatol 1998;37:895-900.
6. Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol 1997;24:654-62.
7. Lieberman JR, Roth KM, Elsissy P, Dorey FJ, Kobashigawa JA. Symptomatic osteonecrosis of the hip and knee after cardiac transplantation. J Arthroplasty 2008;23:90-6.
8. Lieberman JR, Scaduto AA, Wellmeyer E. Symptomatic osteonecrosis of the hip after orthotopic liver transplantation. J Arthroplasty 2000;15:767-71.
9. Colwell CW Jr, Robinson CA, Stevenson DD, Vint VC, Morris BA. Osteonecrosis of the femoral head in patients with inflammatory arthritis or asthma receiving corticosteroid therapy. Orthopedics 1996;19:941-6.
10. Yamamoto T, Irisa T, Sugioka Y, Sueishi K. Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum 1997;40:2055-64.
11. Miyanishi K, Yamamoto T, Irisa T, et al. A high low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a potential risk factor for corticosteroid-induced osteonecrosis in rabbits. Rheumatology Oxford 2001;40:196-201.
12. Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y. Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum 2004;50:3387-91.
13. Hedri H, Cherif M, Zouaghi K, et al. Avascular osteonecrosis after renal transplantation. Transplant Proc 2007;39:1036-8.
14. Wing PC, Nance P, Connell DG, Gagnon F. Risk of avascular necrosis following short term megadose methylprednisolone treatment. Spinal Cord 1998;36:633-6.
15. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002;32:94-124.
16. Radke S, Battmann A, Jatzke S, Eulert J, Jakob F, Schütze N. Expression of the angiomatrix and angiogenic proteins CYR61, CTGF, and VEGF in osteonecrosis of the femoral head. J Orthop Res 2006;24:945-52.
17. Nauck M, Roth M, Tamm M, et al. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol 1997;16:398-406.
18. Masada T, Iwakiri K, Oda Y, et al. Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid-induced osteonecrosis in a rabbit model. J Orthop Res 2008;26:91-5.